Entering the era of molecular-targeted precision surgery in recurrent prostate cancer
Standard
Entering the era of molecular-targeted precision surgery in recurrent prostate cancer : J Nucl Med. / Maurer, T.; van Leeuwen, F. W. B.; Schottelius, M.; Wester, H. J.; Eiber, M.
in: J NUCL MED, Jahrgang 60, Nr. 2, 02.2019, S. 156-157.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Entering the era of molecular-targeted precision surgery in recurrent prostate cancer
T2 - J Nucl Med
AU - Maurer, T.
AU - van Leeuwen, F. W. B.
AU - Schottelius, M.
AU - Wester, H. J.
AU - Eiber, M.
N1 - Hot topic
PY - 2019/2
Y1 - 2019/2
KW - Molecular Imaging Oncology: GU Psma Radiopharmaceuticals fluorescence hybrid tracer radioguided surgery salvage surgery
U2 - 10.2967/jnumed.118.221861
DO - 10.2967/jnumed.118.221861
M3 - Other (editorial matter etc.)
VL - 60
SP - 156
EP - 157
JO - J NUCL MED
JF - J NUCL MED
SN - 0161-5505
IS - 2
ER -